P&G cuts fiscal 2026 GAAP EPS outlook on higher restructuring charges
Procter & Gamble reported fiscal second-quarter 2026 net sales of $22.2 billion, up 1%, while organic sales were unchanged and diluted EPS fell 5% to $1.78 on higher restructuring charges. The company lowered its fiscal 2026 diluted EPS growth outlook to 1% to 6% from 3% to 9%, but kept its core EPS, sales and cash return guidance, so shareholders face lower reported earnings even as underlying results held steady.
Key points
- Net sales of $22.2 billion, up 1%; organic sales unchanged for the quarter ended December 31, 2025.
- Diluted EPS of $1.78, down 5%; core EPS of $1.88, unchanged from the prior year.
- Fiscal 2026 diluted EPS growth outlook cut to 1% to 6% from 3% to 9%; core EPS growth outlook of in-line to up 4% maintained.
- Returned $4.8 billion to shareowners in the quarter: $2.5 billion in dividends and $2.3 billion in share repurchases.
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 22, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.